Clinical Trial Update: (GluEsk) Glutamate and Esketamine [NA]

View source ↗

Summary

A completed University of Oxford clinical trial evaluating glutamate and esketamine for depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Esketamine (esketamine)
• Glutamate (glutamate)

Snippet

Sponsor: University of Oxford | Conditions: Depression | NA | Status: COMPLETED